Background: The main defence against bacterial infection is oxidative killing by neutrophils, which requires molecular oxygen in wounded tissues. High inspired-oxygen fractions increase tissue oxygenation. But, whether improving tissue oxygenation actually reduces surgical-site infection (SSI) remains controversial. We therefore tested the primary hypothesis that supplemental oxygen (80% vs 30%) reduces the risk of a 30-day composite of deep tissue or organespace SSI, healing-related wound complications, and mortality. Methods: In an isolated suite of operating rooms, the inspired-oxygen concentration was alternated between 30% and 80% at 2-week intervals for 39 months. The analysis was restricted to patients who had major intestinal surgery lasting at least 2 h. Qualifying operations (5749) were analysed, including 2843 (49%) colorectal resections, 1866 (32%) lower gastrointestinal therapeutic procedures, 373 (6%) small-bowel resections, and 667 (13%) other colorectal procedures. Results: The 80% and 30% oxygen groups were well balanced on all of the demographic, baseline, and procedural variables. The oxygen intervention had no effect on the composite primary outcome or any of its components. The overall observed incidence of the composite outcome was 10.8% (314/2896) in the 80% oxygen group and 11.0% (314/2853) in the 30% group. The estimated relative risk was 0.99 (95% CI: 0.85, 1.14) for 80% vs 30%, P¼0.85. Conclusions: Supplemental oxygen does not prevent major infection and healing-related complications after major intestinal surgery. Clinical trial registration: NCT01777568.
Editor's key points
Tissue oxygenation is reliant on adequate perfusion of oxygenated blood; haemoglobin is key. Supplemental oxygen had previously been shown to reduce wound infection, but the weight of evidence no longer supports this. This study used a novel design, alternating commonly used treatment options in a quality-improvement framework.
The incidence of surgical-site infection (SSI) and complications related to wound healing in colorectal patients is approximately 10e15%. 1 On average, each complication prolongs the duration of hospitalisation by about a week and adds about $5000 to hospital cost of care. 2 Investigators in Denmark, for example, estimate that surgical-wound infections account for 0.5% of the entire country's hospital budget. 3 Patients who develop a wound infection are twice as likely to require intensive-care-unit care and twice as likely to die as those who do not. 2 The main determinant of whether contamination proceeds to clinical infection is host defence, with the primary defence against surgical pathogens being oxidative killing by neutrophils. Assuming adequate perfusion, the easiest, safest, and most effective way to improve tissue oxygenation is to increase the fraction of inspired oxygen. 4, 5 However, there is considerable controversy as to whether supplemental oxygen actually reduces SSI and healing-related complications. Two relatively large randomized trials (n¼500 and n¼300), 4,6 a smaller trial, 7 and a registry analysis 8 suggest that supplemental oxygen (80% vs 30%) halves infection risk. In contrast, the 1400-patient PROXI trial 9 and our recently published 568-patient trial 10 found no benefit of supplemental oxygen. The available literature thus provides no clear guidance on whether supplemental oxygen reduces infection and woundrelated complications. Despite considerable divergence in reported results, the World Health Organization recommends that 'adult patients undergoing general anaesthesia with endotracheal intubation for surgical procedures should receive an 80% postoperative period for 2e6 hours to reduce the risk of SSI'. 11 The US Centers for Disease Control and Prevention (CDC) similarly recommends supplemental oxygen to reduce infection risk. 12 Oxygen management for colorectal surgery remains divergent, reflecting the lack of clear outcome data. In Europe, most patients are given 30% oxygen during general anaesthesia. In the United States, concentrations range from 30% to 100%. At the Cleveland Clinic, the most common concentration is near 50%, but spans the entire range from 30% to 100%. As part of our quality-improvement process, we are developing an enhanced recovery pathway for colorectal surgical patients. One question that arose was whether the pathway should specify inspired-oxygen concentration. The cost of supplemental oxygen is trivial, typically a few cents per patient. And the safety profile of supplemental (80%) oxygen is reasonably well established. 13, 14 But, whether providing extra oxygen actually reduces the risk of infectious and other wound complications remains controversial. We, therefore, tested the primary hypothesis that supplemental oxygen (80% vs 30% as tolerated) reduces the risk of a 30-day collapsed composite (one or more) of SSI, healing-related wound complications, and mortality.
Methods
The study was restricted to a physically distinct suite of operating rooms, five of which are primarily used by the Department of Colorectal Surgery, Cleveland Clinic, Cleveland, OH, USA and are normally staffed by a small group of anaesthesiologists. Furthermore, most operations performed in the suite are substantial and require postoperative hospitalisation. Typically, about 150 major intestinal procedures per month are performed in this suite. Both the anaesthesia and surgical teams agreed to the proposed project. All patients cared for in the designated operating room suite participated. The designated operating-room suite alternated between using either 30% oxygen as tolerated or 80% oxygen for periods of 2 weeks. For example, the first period used 30% oxygen, the second 80% oxygen, and so on. The oxygen concentration during the initial period was randomly designated by the study statistician. But, thereafter, oxygen delivery was not randomized on a per-patient or even per-period basis. As a safety measure, enough oxygen was always given to maintain oxygen saturation (as determined by pulse oximetry) !95%, anticipating that many patients assigned to 30% oxygen would actually require somewhat more. All clinicians retained full authority to use any indicated inspired-oxygen concentration in specific patients per their judgement.
The providers were notified of the designated oxygen concentration for each 2-week period by e-mail notices and signs on each anaesthesia machine. Our decision-support system was also programmed to recognize non-compliant oxygen concentrations and send alerts via the hospital paging system to the in-room provider, the attending anaesthesiologist, and an investigator. The trigger thresholds for 80% weeks were inspired-oxygen concentrations <70% or >90%; the threshold for 30% weeks was an inspired-oxygen concentration >35% and oxyhaemoglobin saturation !95%. See Supplemental material for additional details about the benefits and limitations of alternating intervention trials.
There were no other restrictions on anaesthetic management, and practitioners were free to use i.v. anaesthetics and neuraxial analgesia per their preference. Positive endexpiratory pressure (PEEP) was not controlled, but was typically set to 5 cm H 2 O. All surgical patients at the Cleveland Clinic are warmed with forced air intraoperatively; prewarming was not used. Mechanical bowel preparation was used selectively and was usually accompanied by oral antibiotics taken the day before surgery. Oral antibiotic prophylaxis, when used, typically consisted of neomycin 1000 mg and metronidazole 500 mg at 9:00 PM and repeated at 11:00 PM the night before the surgery. Prophylactic i.v. antibiotics were given intravenously within an hour before incision, according to the Surgical Care Improvement Project guidelines. 15 There were no major changes in surgical or anaesthetic management during the study period, for example, activation of a new enhanced recovery pathway.
Measurements
All values used in the analysis were obtained from various registries, including patient and morphometric characteristics. Our secondary outcome was superficial SSI, defined by colorectal-surgery fellows in their chart review using all available tests, symptoms, and clinical judgement.
Data analysis
Although all patients in the designated operating room suite participated in the oxygen alternation, we restricted the analysis to those having deep tissue or organespace intestinal surgery lasting at least 2 h. We excluded paediatric patients (<18 yr old), surgeries with missing oxygen data or any covariables, or reoperations during a single hospital visit ( Fig. 1 ). All restrictions were established before inspecting the data. Inspired-oxygen concentration is reported as the timeweighted average (TWA) over the entire intraoperative period.
We descriptively compared the 80% vs 30% oxygen groups on demographic, baseline, and procedural variables using standard descriptive statistics and absolute standardized difference (ASD). Summary statistics are presented as % of patients, means (SDs), or medians [25th percentile (Q1), 75th percentile (Q3)] as appropriate. The ASD was calculated as the absolute difference in means or proportions divided by the pooled SD. We planned adjusted analyses for variables that were imbalanced between groups (defined as ASD >0.10) to reduce potential confounding.
We assessed the effect of 80% vs 30% target inspiredoxygen concentration on the 30-day composite of deep and organespace SSI and healing-related wound complications plausibly influenced by tissue oxygenation, including anastomotic leak, intra-abdominal abscess, sepsis, and wound dehiscence. In-hospital mortality was included in the primary composite per routine to limit survivor bias. (The decision to include mortality was made before data analysis.) The analysis was based on a generalized estimating equation (GEE) model with log link (to estimate the relative risks instead of odds ratios). The model adjusted for within-patient correlation across possible multiple operations on different visits (exchangeable correlation structure). Additionally, we assessed the effect of 80% oxygen on each individual component of the primary composite using the same method.
Subgroup analyses
We further assessed the treatment effect on the collapsed composite outcome within levels of the following seven factors, and the interaction between the treatment effect and each factor: 1) type of surgery (colorectal resection, others); 2) age (<60 vs !60 yr); 3) ASA physical status (IeII vs IIIeV); 4) primary diagnosis (cancer vs others); 5) body mass index (BMI)
(<30 vs !30 kg m À2 ); 6) smoking (current vs never/quit); and 7)
surgery type (open vs laparoscopic). Analogous to the primary analyses, we used GEE models for assessing the treatment-byfactor interactions and treatment effect within levels of each factor. The results are reported as relative risks. The significance criterion was 0.05 for the overall assessment of the collapsed composite outcome, and was 0.008 for each individual component of the composite outcome (i.e. 0.05/6). For the subgroup analyses, the significance criterion was 0.0036 for each comparison (i.e. 0.05/14). SAS 9.4 software (SAS Institute, Cary, NC, USA) was used.
Sample size
The incidence of SSI and potentially oxygen-related wound complications is about 12%. A 20% reduction in composite outcome risk would be of considerable clinical importance. We, therefore, planned to enrol about 5000 patients, which would provide more than 90% power at a two-sided a value of 0.05.
Based on our recent study comparing sevoflurane and isoflurane in the same population, we expected about 150 patients per month to qualify for the proposed qualityimprovement initiative. To assure sufficient qualifying patients, we thus planned to enrol patients for about 3 yr. Although we evaluated compliance with oxygen targets at intervals, there were no interim analyses of outcomes. Instead, a single analysis of outcomes was conducted upon completion of the study.
Study approval
Our quality-improvement project was registered at ClinicalTrials.gov (NCT01777568) and approved by the Cleveland Clinic Institutional Review Board (IRB). The IRB waived individual consent for the alternating intervention project because, 1) 80% supplemental oxygen may well be beneficial and does not present more than minimal risk; 2) the research was not regulated by the Food and Drug Administration; 3) our alternating intervention approach (described below) could not practically be conducted with individual consent; and 4) it was largely a quality-improvement project, and quality interventions do not require IRB approval.
Results
This study was conducted at the Cleveland Clinic main campus from January 28, 2013 to March 11, 2016 . Qualifying colorectal surgeries (5749) from 4481 patients were analysed, including 2843 (49%) colorectal resections, 1866 (32%) lower gastrointestinal therapeutic procedures, 373 (6%) small-bowel resections, and 667 (13%) other colorectal procedures ( Table 1) .
The 80% and 30% oxygen groups were well balanced on all of the demographic, baseline, and procedural variables (ASD <0.10, Table 1 ). Therefore, no adjustment for any potential confounder was needed in all analyses comparing the two groups. The median intraoperative average oxygen concentration was 80% [Q1, Q3: 77%, 82%] for patients in the 80% group, and 39% [35%, 52%] for patients in the 30% group (Fig. 2) .
Our oxygen intervention had no effect on the collapsed composite of 30-day SSI, healing-related wound complications, and mortality, or on any of its components ( Table 2) . The overall observed incidence of the composite outcome was 10.8% (314/2896) in the 80% oxygen group, and 11.0% (314/2853) in the 30% group. The estimated relative risk was 0.99 (95% CI: 0.85, 1.14) for 80% vs 30%, P¼0.85. Furthermore, the treatment effect did not depend on any of the following seven factors (interaction P-value): type of surgery (0.34), age (0.35), ASA physical status (0.60), primary diagnosis (0.62), BMI >30 (0.42), smoking status (0.22), and laparoscopic vs open surgery (0.054). For informational purposes, the estimated treatment effect within the various post hoc subgroups is shown in Fig. 3 .
Our oxygen intervention did reduce the superficial SSIs; the observed incidence was 5.2% (150/2896) in the 80% oxygen group and 6.4% (183/2853) in the 30% group. The estimated relative risk was 0.80 (95% CI: 0.66, 1.00) for 80% vs 30%, P¼0.047.
Discussion
Our trial of supplemental oxygen and SSI enrolled nearly of many patients of all previous relevant studies combined. The results were clear: supplemental oxygen had no effect on our primary outcome, a 30-day composite of SSI, healing-related wound complications, and mortality. Oxygen also had no effect on any component of our primary composite outcome. Furthermore, because so many patients were included, CIs around our results were tight, making it unlikely that results will differ substantially in future trials. We thus conclude that clinicians should not give supplemental oxygen in an effort to prevent infections and healing-related complications.
Our results contrast with the 2017 CDC recommendation that surgical patients should be given supplemental oxygen during and after surgery. 12 They also contrast with the 2016
World Health Organization recommendation to provide 80% intraoperative oxygen, but are consistent with two negative trials with a total of 752 patients 10, 19 that curiously were not included in the CDC's analysis. This is our fourth major trial of supplemental oxygen and SSI conducted over more than two decades. The first two showed benefit, 4, 6 whereas the third did not 10 and was consistent with the PROXI trial results. 9 There are some differences in that our previous studies were restricted to colon resections (although the PROXI trial was not). However, there was no disparate treatment effect in our current colonresection patients compared with patients who have other types of colorectal surgery. Previous studies included several hours of postoperative oxygen treatment, whereas our current trial was restricted to intraoperative oxygen. However, we have previously shown that supplemental oxygen restricted to the postoperative period does not reduce wound-infection risk. 20 It is also possible that supplemental oxygen is no longer effective, because its benefits are masked by two decades of improved surgical technique, including use of wound protectors and changing gloves during wound closure. And finally, the primary outcome for previous studies was wound infection, rather than our current composite of SSI, healing-related wound complications, and inhospital mortality. However, the results were similar when the analysis was restricted to SSI. It thus seems unlikely that methodological differences explain divergences with previous publications. In contrast to our primary outcome, the incidence of superficial infections was reduced 20%. However, the reduction for this secondary outcome was only barely statistically significant despite our large sample size. Given that superficial infections are so much less serious than any component of our Continued primary outcome, the observed small reduction probably does not justify the use of supplemental oxygen. Because our current study is so large, it presumably provides the most robust results, especially as it is consistent with the largest recent trials, representing z2000 randomized patients. This trajectory of trial results for >15 yr raises two interesting questions. First, why were the initial studies wrong? Both were well-conducted trials, but small initial trials often over-estimate the treatment effect determined in subsequent larger trials. 21 Whilst trials with 500 and 300 randomized patients are not small by conventional standards, they do not provide robust estimates for relatively uncommon dichotomous outcomes, such as SSI. Second, why is supplemental oxygen salutatory in biochemical analyses, and yet lacks benefit in recent trials? Oxidative killing varies over the full range from 0 to !150 mm Hg oxygen. 22 Oxidative killing requires molecular oxygen that is enzymatically transformed to the bactericidal radical superoxide. 23 Subcutaneous-tissue oxygen values near 60 mm
Hg are typical in euthermic, euvolemic, and healthy volunteers breathing room air. 24 Perioperative subcutaneous oxygen partial pressures <50 mm Hg whilst breathing supplemental oxygen are associated with high infection risk, whereas partial pressures >90 mm Hg are rarely associated with infection. 25 Adequate tissue oxygenation is also necessary for collagen deposition (scar formation), which is an essential step in wound healing and tissue repair. 26 However, the 'doseeresponse' curve for oxidative killing is highly non-linear, with tissue oxygen partial pressures less than 60 mm Hg disproportionately impairing oxidative killing. Even 30% inspired oxygen typically produces tissue partial pressures near 60 mm Hg. Tissue partial pressures are nearly doubled when surgical patients breathe 80% oxygen, but the effect on oxidative killing is far less, as the concentrationeresponse curve is relatively flat in this range. 22 Our results suggest that 30e40% inspired oxygen is sufficient to support oxidative killing by neutrophils, and that other factors matter more than inspired oxygen once some critical tissue partial pressure is maintained. This is consistent with studies showing that hypercapnia and supplemental fluid administration both increase subcutaneous-tissue oxygenation, but do not reduce surgical-wound infections. The putative mechanism by which supplemental oxygen might ameliorate infection risk is by enhancing oxidative killing by neutrophils in wounded tissues. 30, 31 The primary determinants of wound oxygen are arterial oxygen content and partial pressure, and tissue perfusion. 32 Vascular volume is one determinant of perfusion, making fluid management a potentially important factor. In the extreme, for example, even an excellent arterial partial pressure will not improve oxygenation of ischaemic tissue. 33 Consistent with this theory, generous fluid management enhances tissue oxygenation 28 dalthough it did not significantly reduce infections (in an under-powered study). The patients in our earlier study were given approximately 14 ml kg À1 h À1 of crystalloids, 4 whereas our current patients were about 10 ml kg À1 h
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. The more restrictive approach is consistent with the worldwide trends. Whilst it remains possible that oxygen would be beneficial in patients given more fluid, it seems unlikely that clinicians will revert to generous fluid replacement given that large volumes appear to provoke other complications. Our results thus apply to patients managed per current clinical routine.
A limitation of our trial is that our outcomes were abstracted from the Colorectal Department, Cleveland Clinic registry and the clinic's billing system rather than from individual evaluation by investigators. Furthermore, postdischarge infections were evaluated by a chart review, which would include any in-or outpatient contact with the Cleveland Clinic providers. But, it would miss patients who chose to continue care elsewhere. Undoubtedly, we missed a fraction of infections and healing-related complications, but there is little reason to believe that loss to follow-up was related to treatment or constituted a measurement bias.
The patients assigned to 80% intraoperative oxygen had a time-weighted median inspired concentration close exactly equal to the designated 80% target. In contrast, the patients assigned to 30% had an actual time-weighted median inspired concentration of 39% [Q1, Q3: 35%, 52%], which might appear to be a protocol deviation. But, in fact, the protocol specifies that, in all patients, 'enough oxygen will always be given to maintain oxygen saturation (as determined by pulse oximetry) !95%'. The higher-than-targeted concentration was thus per protocol and reflects the fact that patients having laparoscopic surgery, often in steep Trendelenburg position, frequently need more than 30% inspired oxygen to maintain normal saturation.
Oxygen (100%) causes atelectasis within a few breaths, 42 although that atelectasis is also easily and largely reversible by a few large positive-pressure breaths 43, 44 or PEEP. 45 In contrast, many studies show that 80% oxygen does not cause atelectasis or any other pulmonary complications. 13, 42, 46, 47 Interestingly, the patients in the PROXI trial given 80% supplemental oxygen reportedly suffered greater long-term mortality: hazard ratio 1.30 (95% CI, 1.03e1.64), P¼0.03. Increased mortality was essentially restricted to patients with cancer. 9 Postulated explanations include increased tumour growth as a result of hyperoxia-induced neovascularization, increased erythropoietin release, and DNA damage by oxygen-triggered reactive oxygen species. 23, 48 A subsequent PROXI data analysis reported that new or recurrent cancers occurred at a similar rate in patients given 30% or 80% oxygen, but that new or recurrent cancer was observed slightly earlier in patients randomized to 80% oxygen. 49 However, new or recurrent cancersdwhich occurred just 100 days earlier over a 5 yr perioddwere insufficient to explain excess mortality in the 80% oxygen group. Box plot of average oxygen concentration during surgery in the 80% and 30% target oxygen groups. The first quartile, median, and third quartile comprise the boxes; whiskers extend to the most extreme observations within 1.5 times the interquartile range of the first and third quartiles, respectively. Table 2 Primary results: relative risk of 30-day mortality and major infection-related complications in 80% vs 30% oxygen (N¼5749). A single patient can experience more than one complication, and so the numbers in each column do not total to the 'any of the above' total. *We assessed the effect of 80% vs 30% oxygen using a GEE model with log link (to estimate the relative risk instead of the odds ratio). The model adjusts for year of surgery and the within-patient correlation across possible multiple operations on different visits (exchangeable correlation structure). A recent analysis of mortality in more than 900 patients who had colon resections in our previous oxygen-infection studies did not identify increased mortality in patients given 80% oxygen.
14 This study included many Cleveland Clinic patients (although none in the current trial), suggesting that supplemental oxygen does not increase mortality in patients similar to the ones enrolled in our current trial. It will be of considerable interest to re-evaluate our current cohortdmany of whom had surgery for cancerdsome years from now to confirm that supplemental oxygen does not augment mortality. In summary, 80% inspired oxygen had no effect on our primary outcome, a 30-day composite of mortality, major SSI, and healing-related complication. Supplemental oxygen also had no effect on any component of our primary composite outcome, including deep and organespace wound infection. Nor did treatment effect vary by subgroup, including in patients who had colon resections. Because our trial was large, the results are robust, leading us to conclude that, despite recent World Health Organization 11 and CDC 12 guidance, clinicians should not give supplemental oxygen in an effort to prevent infections and healing-related complications after a major intestinal surgery.
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